NYSE Arca · NAIL

Direxion Daily Homebuilders & Supplies Bull 3X ETF (NAIL)

$32.90−5.11%
Close Nov 12, 2026 · split-adjusted
Nov 12, 2026$32.90▼ 42.02% in range
Nov 12, 2025Low $24.52 · High $77.60Nov 12, 2026
What changed · written from our data
As of Nov 12, 2026

Direxion Daily Homebuilders & Supplies Bull 3X ETF closed at $32.90 on Nov 12, down 5.11%, 57.6% below its 52-week closing high. Volume of 834.3K shares was 0.44× its 20-day average (below normal).

Split-adjusted performance: +34.2% over one month, -5.5% over six months, -42.5% over one year.

Short interest was 1.2M shares at the Oct 30 settlement, down 38.9% from the prior report (1.0 days to cover).

Market cap$516.5M15.7M shares
Revenue · quarter——
Diluted EPS——
P/E · TTM—
Net margin—
Dividend yield1.41%$0.1162 last paid
52-week range24.52 – 77.60−57.6% from high
Volume834.3K0.44× 20-day avg
Volatility · 60d98.2%Annualised
Short % of float—1.0 days to cover
Net cash—
Next earnings—Not scheduled
Split-adjusted performance
1W −14.9%1M +34.2%3M −21.3%6M −5.5%YTD −33.7%1Y −42.5%3Y −44.1%5Y −62.5%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—
Revenue growth—
Net margin—
Value (low P/E)—
Size—

Short interest

Details →
Shares short1.2M−38.9% vs prior
Days to cover1.0Settled Oct 30
% of float—
Short vol. 10d36.0%of daily volume

News about Direxion Daily Homebuilders & Supplies Bull 3X ETF

All news →

No recent articles focused on Direxion Daily Homebuilders & Supplies Bull 3X ETF.

Quick answers

What is NAIL's market cap?
$516.53M, based on the Nov 12 close of $32.90.
Does Direxion Daily Homebuilders & Supplies Bull 3X ETF pay a dividend?
Yes. The latest regular dividend was $0.1162 per share (ex-date Sep 22), an annualised yield of 1.41%.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology